Why Anti-Vaxxers Could Help Boost Earnings for Pfizer
Text size A large, vaccine-skeptic population could be a boon for Pfizer’s Paxlovid. Courtesy of Pfizer America’s drugmakers played key roles in developing Covid-19 vaccines, but the country ranks well below 50th on the percentage […]